豚鼠胰腺內(nèi)telocytes形態(tài)學特點及甲磺酸伊馬替尼對telocytes的干預作用
[Abstract]:Objective to observe and analyze the morphologic characteristics of telocytes-TCs in guinea pig pancreas and to investigate the effect of imatinib mesylate on TCs. Methods Nine-week-old guinea pig pancreas was used to observe and analyze TCs immunological markers (c-kit / CD _ (117) vimentin) by immunohistochemical staining. The ultrastructure of TCs was observed by transmission electron microscope. The model of imatinib mesylate intervention was established: 54 guinea pigs, male and female, were divided into two groups: normal control group and control group. The changes of TCs were observed by immunohistochemical staining of TCs in the treated group (W _ (14) W _ (14) W _ (21) W _ (21) and W _ (28) d); and the expression of CD117vimentin protein in pancreatic tissue was observed by Western blot. Results Immunohistochemical staining showed that TCs in the pancreas was located in connective tissue. The cells were triangular and fusiform. There were one or more long and thin processes around the acinar and connected to form the network structure. The ultrastructure of electron microscope showed that TCs had the slender bulge of rosary, the nucleus and cytoplasm were relatively high, the cytoplasm contained a small amount of mitochondria and the smooth endoplasmic reticulum, etc. After the intervention of imatinib mesylate, the process of TCs became shorter, the network structure decreased, and gradually recovered after drug withdrawal. After treatment, the expression of c-kit/CD117 and vimentin protein in pancreatic tissue decreased, and gradually recovered after withdrawal, the difference was statistically significant (P0.05). Conclusion in the pancreas of guinea pig, the spindle shape and the rosary protuberance form the network structure around the acinar, and imatinib mesylate affects the morphology and protein expression of TCs in the pancreas.
【作者單位】: 貴州醫(yī)科大學基礎醫(yī)學院人體組織學與胚胎學教研室;
【基金】:貴州省科技廳基金{黔科合J字[2008]2277} 貴陽市科技局貴州醫(yī)科大學聯(lián)合基金{[20161001]013}~~
【分類號】:R965
【相似文獻】
相關期刊論文 前10條
1 鄭斌;危晴嵐;劉茂柏;;甲磺酸伊馬替尼臨床研究概況[J];海峽藥學;2006年06期
2 李玉蘭;;極譜法測定尿液中甲磺酸伊馬替尼含量[J];藥物分析雜志;2008年06期
3 李銘東;李東;吉民;;甲磺酸伊馬替尼的合成[J];中國藥學雜志;2008年03期
4 付利強;王鵬;程卯生;趙冬梅;;甲磺酸伊馬替尼合成路線圖解[J];中國醫(yī)藥工業(yè)雜志;2008年10期
5 趙瑾;姜達;;甲磺酸伊馬替尼耐藥機制及其逆轉研究進展[J];癌癥進展;2009年02期
6 許鵬飛;張春桃;;甲磺酸伊馬替尼合成新工藝[J];科技傳播;2010年23期
7 陳靈娟;周和平;黃文峰;閆明;姚軍;;甲磺酸伊馬替尼的合成[J];河北科技大學學報;2011年05期
8 王保國;劉玉鳳;狄國杰;許鵬飛;朱鵬;付茂文;;甲磺酸伊馬替尼的合成[J];濟寧醫(yī)學院學報;2012年02期
9 劉穎;張克星;蘭靜;王yN;田青松;;離子色譜法測定甲磺酸伊馬替尼中甲磺酸[J];現(xiàn)代藥物與臨床;2012年04期
10 丁倩倩;陳勤奮;;甲磺酸伊馬替尼的臨床應用[J];上海醫(yī)藥;2013年03期
相關重要報紙文章 前2條
1 上海華聯(lián)制藥有限公司技術中心 馬培奇;抗腫瘤新藥:甲磺酸伊馬替尼[N];中國高新技術產(chǎn)業(yè)導報;2001年
2 伊遙;洋品牌的幸福時光[N];醫(yī)藥經(jīng)濟報;2012年
相關碩士學位論文 前1條
1 杜艷玲;甲磺酸伊馬替尼及其片劑的質(zhì)量標準研究[D];河北醫(yī)科大學;2015年
,本文編號:2159665
本文鏈接:http://sikaile.net/yixuelunwen/yiyaoxuelunwen/2159665.html